Literature DB >> 9345116

Risk factors for hospitalization in a cohort with type 1 diabetes. Wisconsin Diabetes Registry.

M Palta1, T LeCaire, K Daniels, G Shen, C Allen, D D'Alessio.   

Abstract

The authors investigate the postonset hospitalization rate and risk factors during 1987-1994 in Wisconsin, in a population-based, incidence cohort followed from diagnosis of Type 1 diabetes mellitus at ages 0-29 (n = 577). The overall rate was 8.9 +/- 0.60 (standard error) per 100 person-years of diabetes, whereof 5.7 was due to hyperglycemia, 1.9 to hypoglycemia, and 1.3 to other and undetermined causes. Major risk factors for hospitalization were longitudinally measured glycosylated hemoglobin level (rate ratio = 1.5 per 2% increase, 95% confidence interval 1.4-1.7), black/other race (rate ratio = 1.9, 95% confidence interval 1.0-3.6), diagnosis in a non-university-based setting (rate ratio = 1.9, 95% confidence interval 1.2-3.2), female sex (rate ratio = 1.5, 95% confidence interval 1.0-2.4 at age 11), age in males (rate ratio = 0.6, 95% confidence interval 0.4-0.8 per 5-year increase), and public or no insurance up to 18 months postdiagnosis (rate ratio = 2.2, 95% confidence interval 1.1-4.4). For individuals less than 18 years, "black/other race" was replaced in the model by "having other than two biologic parents in the home" (rate ratio = 2.0, 95% confidence interval 1.1-3.5). Hence, hospitalization is common in children, adolescents, and young adults with diabetes, primarily for problems with glycemic control.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345116     DOI: 10.1093/oxfordjournals.aje.a009328

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  17 in total

1.  Biopsychosocial pathways linking subjective socioeconomic disadvantage to glycemic control in youths with type I diabetes.

Authors:  Samuele Zilioli; Deborah A Ellis; Justin M Carré; Richard B Slatcher
Journal:  Psychoneuroendocrinology       Date:  2017-02-03       Impact factor: 4.905

2.  The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes.

Authors:  Kirstie K Danielson; Mari Palta; Catherine Allen; Donn J D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2005-10-04       Impact factor: 5.958

3.  Maternal body mass index (BMI) is independently associated with the control of diabetes mellitus in young patients.

Authors:  Sarah A Sobotka; Kirstie K Danielson; Melinda L Drum; Carmela L Estrada; Rebecca B Lipton
Journal:  Pediatr Nurs       Date:  2014 Jul-Aug

4.  The trajectory of IGF-1 across age and duration of type 1 diabetes.

Authors:  Mari Palta; Tamara J LeCaire; Mona Sadek-Badawi; Victor M Herrera; Kirstie K Danielson
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

5.  Oestradiol levels may differ between premenopausal women, ages 18-50, with type 1 diabetes and matched controls.

Authors:  Lina Saleh Hassan; Rebecca S Monson; Kirstie K Danielson
Journal:  Diabetes Metab Res Rev       Date:  2016-06-30       Impact factor: 4.876

6.  Oxytocin levels are lower in premenopausal women with type 1 diabetes mellitus compared with matched controls.

Authors:  Amber S Kujath; Lauretta Quinn; Mary E Elliott; Krista A Varady; Tamara J LeCaire; C Sue Carter; Kirstie K Danielson
Journal:  Diabetes Metab Res Rev       Date:  2014-09-03       Impact factor: 4.876

Review 7.  Racial and Ethnic Disparities in Adverse Drug Events: A Systematic Review of the Literature.

Authors:  Avi Baehr; Juliet C Peña; Dale J Hu
Journal:  J Racial Ethn Health Disparities       Date:  2015-03-24

8.  Hospitalization subsequent to diagnosis in young patients with diabetes in Chicago, Illinois.

Authors:  Carmela L Estrada; Kirstie K Danielson; Melinda L Drum; Rebecca B Lipton
Journal:  Pediatrics       Date:  2009-08-10       Impact factor: 7.124

9.  Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.

Authors:  Ashley Pinckney; Mark R Rigby; Lynette Keyes-Elstein; Carol L Soppe; Gerald T Nepom; Mario R Ehlers
Journal:  Clin Ther       Date:  2016-05-18       Impact factor: 3.393

10.  Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes.

Authors:  K K Danielson; M E Elliott; T LeCaire; N Binkley; M Palta
Journal:  Osteoporos Int       Date:  2008-10-02       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.